首页> 外国专利> METHOD FOR PREDICTION OF DEVELOPMENT OF HELICOBACTER PYLORI-NEGATIVE GASTROPATHIA IN PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION WITH CHRONIC CARDIAC INSUFFICIENCY

METHOD FOR PREDICTION OF DEVELOPMENT OF HELICOBACTER PYLORI-NEGATIVE GASTROPATHIA IN PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION WITH CHRONIC CARDIAC INSUFFICIENCY

机译:预测原发性高血压伴慢性心功能不全的患者幽门螺杆菌阴性胃病的发展方法

摘要

Method for prediction of development of complications in patients with essential arterial hypertension with chronic cardiac insufficiency includes determination of characteristics of lipid metabolism. Prediction of development of helicobacter pylori-negative gastropathias in this group of patients is carried out through monitoring of the levels of total cholesterol (TCH), total triglicerides (TTG), cholesterol of low density lipoproteides (CS LDLP) and malonic dialdehyde) (MDA), then one determines the values of medians of those characteristics, at that the risk of development of helicobacter pylori-negative gastropathias is predicted at values of medians of TCH 230.55 mg/dl and higher, TTG 162.90 mg/dl and higher, CS LDLSP 155.66 µ/dl and higher, MDA 12.63 µmol/l and higher.
机译:预测患有慢性心脏功能不全的原发性高血压患者并发症发生的方法包括确定脂质代谢的特征。通过监测总胆固醇(TCH),总甘油三酯(TTG),低密度脂蛋白胆固醇(CS LDLP)和丙二醛二醛(MDA)的水平来预测这一组患者中幽门螺杆菌阴性胃病的发展),然后确定这些特征的中位数值,以预测发生幽门螺杆菌阴性胃炎的风险中位数为TCH 230.55 mg / dl和更高,TTG 162.90 mg / dl和更高,CS LDLSP 155.66 µ / dl和更高,MDA 12.63 µmol / l和更高。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号